|
Regression of epithelial cancers in humans following t-cell receptor gene therapy targeting human papillomavirus-16 E7. |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
Employment - Kite, a Gilead company |
Stock and Other Ownership Interests - Kite, a Gilead company |
| |
|
Employment - Agensys; Kite, a Gilead company; Mannkind |
Stock and Other Ownership Interests - Mannkind |
| |
|
Employment - Kite, a Gilead company |
Stock and Other Ownership Interests - Kite, a Gilead company |
Patents, Royalties, Other Intellectual Property - Kite, a Gilead company |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |